{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:57Z","timestamp":1777420857337,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:p>Objective: To summarize the efficacy and safety data for the use of varenicline in the treatment of alcohol use disorders. Data Sources: A literature search was conducted in PubMed, International Pharmaceutical Abstracts, and Cochrane Library (through May 2014). Key search terms included varenicline, alcohol, alcohol dependence, alcoholism, ethanol, and nicotinic acetylcholine receptor. Additional references were identified from literature citations. Study Selection and Data Extraction: Results were limited to clinical trials and case reports that discussed either the use of varenicline in alcohol drinking patients or adverse effects experienced with its use. Only English language studies in humans were reviewed. Data Synthesis: In all, 7 randomized, placebo-controlled clinical trials and 1 open-label study were identified that evaluated the impact of varenicline on various drinking-related end points. The studies were conducted in patients dependent on alcohol (n = 4), non-alcohol-dependent patients (n = 3), and patients with a history of alcohol dependence but who had been abstinent for at least 6 months (n = 1). The majority of the studies classified their participants as heavy drinkers; however, this definition varied across studies. Most studies included smokers, but 2 trials included both smokers and nonsmokers. Conclusions: Evidence supports the use of varenicline for the reduction of alcohol craving as well as for the reduction of overall alcohol consumption in patients with alcohol use disorders. However, it is not likely to improve abstinence rates. Although most of the data were derived from patients with concurrent nicotine dependence, the effects of varenicline appear to occur independent of baseline smoking status.<\/jats:p>","DOI":"10.1177\/1060028014545806","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:57:59Z","timestamp":1407286679000},"page":"1445-1455","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":53,"title":["Varenicline in the Treatment of Alcohol Use Disorders"],"prefix":"10.1177","volume":"48","author":[{"given":"Beth L.","family":"Erwin","sequence":"first","affiliation":[{"name":"University of Alabama at Birmingham (UAB) Hospital, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel M.","family":"Slaton","sequence":"additional","affiliation":[{"name":"Samford University McWhorter School of Pharmacy, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"bibr1-1060028014545806","volume-title":"Basic and Clinical Pharmacology","author":"Masters SB","year":"2012","edition":"12"},{"key":"bibr2-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"bibr3-1060028014545806","unstructured":"World Health Organization. Management of substance abuse: alcohol. http:\/\/www.who.int\/substance_abuse\/facts\/alcohol\/en\/index.html. Accessed October 24, 2013."},{"key":"bibr4-1060028014545806","unstructured":"Varenicline. In: Clinical Pharmacology. Tampa, FL: Gold Standard. http:\/\/clinicalpharmacology-ip.com.ezproxy.sam-ford.edu\/Forms\/Monograph\/monograph. Accessed May 19, 2014."},{"key":"bibr5-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2717-x"},{"key":"bibr6-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e31829623f4"},{"key":"bibr7-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-2160-9"},{"key":"bibr8-1060028014545806","first-page":"1131","volume-title":"Pharmacotherapy: A Pathophysiologic Approach","volume":"2011","author":"Doering PL","edition":"8"},{"key":"bibr9-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2013.12037.x"},{"key":"bibr10-1060028014545806","first-page":"213","volume":"29","author":"Ait-Daoud N","year":"2006","journal-title":"Alcohol Res Health"},{"key":"bibr11-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1016\/j.drug-alcdep.2011.08.025"},{"key":"bibr12-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1097\/JCP-.0b013e3182870551"},{"key":"bibr13-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.08.009"},{"key":"bibr14-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.01.029"},{"key":"bibr15-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalc-dep.2013.06.019"},{"key":"bibr16-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2011.01675.x"},{"key":"bibr17-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1016\/j.euro-neuro.2009.11.001"},{"key":"bibr18-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2014.876008"},{"key":"bibr19-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1523\/JNEU-ROSCI.2601-10.2010"},{"key":"bibr20-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705368104"},{"key":"bibr21-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.06.022"},{"key":"bibr22-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500459529"},{"key":"bibr23-1060028014545806","unstructured":"Varenicline. In: Lexi-Drugs Online (AHFS DI). Hudson, OH: Lexi-Comp. http:\/\/www.crlonline.com.ezproxy.samford.edu. Updated October 4, 2013. Accessed October 25, 2013."},{"key":"bibr24-1060028014545806","unstructured":"Varenicline. In: Micromedex 2.0. Greenwood Village, CO: Thompson Reuters. http:\/\/www.micromedexsolutions-com.ezproxy.samford.edu. Updated October 2, 2013. Accessed October 25, 2013."},{"key":"bibr25-1060028014545806","unstructured":"Chantix [package insert]. New York, NY: Pfizer Inc; 2014."},{"key":"bibr26-1060028014545806","first-page":"5","volume":"164","author":"Kleber HD","year":"2007","journal-title":"Am J Psychiatry"},{"key":"bibr27-1060028014545806","unstructured":"NHS National Institute for Health and Clinical Excellence (NICE). Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. http:\/\/www.nice.org.uk\/guidance\/CG115. Accessed July 22, 2014."},{"key":"bibr28-1060028014545806","doi-asserted-by":"crossref","unstructured":"Department of Veterans Affairs, Department of Defense. VA\/DoD Clinical Practice Guideline for Management of Substance Use Disorders (SUD). Washington, DC: Department of Veterans Affairs, Department of Defense; 2009:1-158.","DOI":"10.21236\/ADA512950"},{"key":"bibr29-1060028014545806","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070641"},{"key":"bibr30-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.20.4.497"},{"key":"bibr31-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12121599"},{"key":"bibr32-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M131"},{"key":"bibr33-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-65"},{"key":"bibr34-1060028014545806","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2011.0199"},{"key":"bibr35-1060028014545806","volume-title":"Behavioral Health Barometer: United States, 2013","author":"Substance Abuse and Mental Health Services Administration","year":"2013"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028014545806","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1060028014545806","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028014545806","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:15:22Z","timestamp":1777374922000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1060028014545806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1177\/1060028014545806"],"URL":"https:\/\/doi.org\/10.1177\/1060028014545806","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]}}}